Manual Lymphatic Drainage Before and After Total Knee Replacement, a Single-center Observer-blinded Randomized Controlled Trial

NCT ID: NCT05119764

Last Updated: 2023-08-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

112 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-01

Study Completion Date

2023-02-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this observer-blinded randomized controlled trial is the evaluation of the influence of manual lymphatic drainage (MLD) on the outcome of patients receiving total knee replacement (TKA).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Total Knee Arthroplasty Manual Lymphatic Drainage MLD Rehabilitation Knee Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial with three treatment groups, two intervention groups and one control group
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators
Observer/Investigators are unaware of the treatment arm of each patient. Patients cannot be blinded, due to the obvious treatment intervention (manual lymphatic drainage 15 minutes for 5 days).

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group

Standard pre- and postoperative physical therapy without manual lymphatic drainage.

Group Type NO_INTERVENTION

No interventions assigned to this group

Manual lymphatic drainage before and after knee replacement

Manual lymphatic drainage before and after knee replacement

Group Type EXPERIMENTAL

Manual Lymphatic Drainage

Intervention Type PROCEDURE

Manual Lymphatic Drainage is a form of physical therapy with the primary goal of accelerating lymphatic drainage.

In this study, the manual lymphatic drainage is applied by experienced physical therapists 5 days in a row for 30 minutes each; after and/or before the surgery.

Manual lymphatic drainage after knee replacement

Manual lymphatic drainage after knee replacement

Group Type EXPERIMENTAL

Manual Lymphatic Drainage

Intervention Type PROCEDURE

Manual Lymphatic Drainage is a form of physical therapy with the primary goal of accelerating lymphatic drainage.

In this study, the manual lymphatic drainage is applied by experienced physical therapists 5 days in a row for 30 minutes each; after and/or before the surgery.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Manual Lymphatic Drainage

Manual Lymphatic Drainage is a form of physical therapy with the primary goal of accelerating lymphatic drainage.

In this study, the manual lymphatic drainage is applied by experienced physical therapists 5 days in a row for 30 minutes each; after and/or before the surgery.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Total Knee Arthroplasty (TKA)

Exclusion Criteria

* Venous insufficiency
* BMI \> 38
* Vascular disease
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bezirkskrankenhaus St. Johann in Tirol

OTHER

Sponsor Role collaborator

Moritz Wagner

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Moritz Wagner

Principal Investigator, Dr. med. univ. Moritz Wagner

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

BKH St. Johann in Tirol

Sankt Johann in Tirol, Tyrol, Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1466/2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.